Reacta Healthcare develop and manufacture challenge meals for use in food allergy clinical trials. Building from this foundation we offer innovative development and manufacturing solutions across the food allergy space.
Reacta Healthcare, established in 2013, operates from a pharmaceutical manufacturing facility in Deeside, North Wales. It is licenced to manufacture challenge meals for use in clinical trials. These challenge meals are currently used to diagnose and monitor food allergy in numerous worldwide therapeutic trials. Patents for the challenge meals have been granted in a number of countries.
Reacta Healthcare is developing its in-house analytical capability and has plans in place for expansion into niche areas of food allergen development and manufacture. This will include all aspects from sourcing through to manufacture of end product.
Certificate of GMP Compliance of a manufacturer certificate number : UK MIA(IMP) 53174 INSP IMP 53174/19385617-0003[I].
Secondary packaging operations restricted to open label, non-randomised activities associated with Non-IMPs / Auxiliary Medicinal Products for use as challenge agents in clinical trials.